Filter by:
Apr 292020
Neuraptive Therapeutics Announces FDA Clearance of IND Application

NTX-001 is a potentially transformative adjunctive treatment for peripheral nerve injuries, using a propriety system for the reconnection of severed…

Continue Reading
Feb 202020
New Rhein – Belgium Investor Day (March 9, 2020)

New Rhein Healthcare Investors invites you to join us for our event, Investing in Healthcare and Life Science Innovations, in Ghent, Belgium, on…

Continue Reading
Sep 172019
New Rhein- Singapore Investor Day (September 17, 2019)

New Rhein Healthcare Investors invites you to join us for our event, Investing in Healthcare and Life Science Innovations, in Singapore on September…

Continue Reading
Dec 192018
Neuraptive Therapeutics Raises $11.5M Series A

LAFAYETTE, Colo., Dec. 19, 2018 /PRNewswire/ -- Neuraptive Therapeutics, Inc. (Neuraptive) announced today that it has secured a $11.5 million Series A equity financing which remains…

Continue Reading
Dec 122018
New Rhein opens US headquarters in Philadelphia and expands investment team

PHILADELPHIA, Dec. 12, 2018 /PRNewswire/ -- New Rhein Healthcare Investors, an international private equity firm has announced moving its global headquarters from Chicago to Philadelphia, complementing its other offices in…

Continue Reading